Skip to content

FDA LDT oversight battle: Are we close?

Release Date: 06 Mar 2024 LabPulse.com
omb m 124 65 87 61983

Meanwhile, Archives of Pathology and Laboratory Medicine's February edition took a critical look at an important laboratory quality step, proficiency testing (PT). The article focused on next-generation sequencing (NGS) assays, a class of LDTs in practice in higher volume in recent years.

For the full article click here: FDA LDT oversight battle: Are we close?

adding all to cart
False 0
File added to media cart.